AI Signal & Stock Analysis · Weak ↓
As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for ABT is Weak ↓; the stock is at $111.32 (+0.04% today); overbought (RSI 72); technical trend is Raise; news sentiment is nan.
Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Weak ↓ |
|---|---|
| Price | $111.32 |
| Change today | +0.04% |
| RSI (14) | 72.41 |
| Relative volume | 0.27 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $192.6B |
| Forward P/E | 18.36 |
| 52-week high | -19.1% away |
| 52-week low | +35.6% above |
| Technical trend | RAISE-2024-01-26 |
| News sentiment | Nan |
| Sector | Healthcare-Devices |
| Next earnings | 7/16/2026 8:30:00 AM |
As of Aug 14 2026, 1:04 PM, AkshayaAI assigns ABT (Abbott Laboratories) a Weak signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
ABT's RSI is overbought (RSI 72). A reading above 70 is typically considered overbought and below 30 oversold.
ABT is trading about 19% below its 52-week high and 36% above its 52-week low as of Aug 14 2026, 1:04 PM.
ABT's next earnings date is 7/16/2026 8:30:00 AM.
ABT is classified under Healthcare-Devices in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.